Abstract
Baseline characteristics of adults with classic congenital adrenal hyperplasia enrolled in CAHtalyst, a phase 3 study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have